Concord Drugs Ltd SHARE PRICE [LIVE]

BSE: INE858L01010   NSE: CONCORD   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
28.80
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Concord Drugs Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

CONCORD News

Frequently Asked Questions

What is the Share price of Concord Drugs Ltd (CONCORD)?

Concord Drugs Ltd (CONCORD) share price as of May 27, 2022, on BSE is Rs 28.80 (BSE).

Can I buy Concord Drugs Ltd (CONCORD) shares?

Yes, You can buy Concord Drugs Ltd (CONCORD) shares by opening a Demat account with Angel One.

How do I buy Concord Drugs Ltd (CONCORD) from Angel One?

Concord Drugs Ltd (CONCORD) share can be brought through the following modes:
  1. Direct investment: You can buy Concord Drugs Ltd (CONCORD) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Concord Drugs Ltd (CONCORD) shares.

In which sector do Concord Drugs Ltd (CONCORD) belong?

Concord Drugs Ltd (CONCORD) belongs to Pharma.

About CONCORD

Today's live share price for Concord Drugs Ltd is NSE: N/A, BSE: ₹ 28.80 with a current market capitalization of .

CONCORD DRUGS LIMITED is a public limited company established in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.

Read more